F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease

Clinical Nuclear Medicine

Volumn 27, Issue 8, 2002, Pages 572-577

  Rini, Josephine N ^a   Manalili, Evelyn Y ^a   Hoffman, Mark A ^a   Karayalcin, Gungor ^a   Mehrotra, Bhoomi ^a   Tomas, Maria B ^a   Palestro, Christopher J ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

F 18 Fluorodeoxyglucose; Ga 67 Scintigraphy; Hodgkin's Disease; Positron Emission Tomography; Splenic Lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOMA; MALE; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN CELL; SPLEEN TUMOR;

ADOLESCENT; ADULT; AGED; CHILD; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPLENIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 0036705882     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200208000-00005     Document Type: Article

References (29)

1. Silecchia G, Fantini A, Raparelli L, et al: Management of abdominal lymphoproliferative diseases in the era of laparoscopy. Am J Surg 177:325, 1999.
2. Glatstein E, Guernsey JM, Rosenberg SA, et al: The value of staging laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 24:718, 1969.
3. Urba WJ, Longo DL: Hodgkin's disease. N Engl J Med 326:678, 1992.
4. Hopper KD, Diehl LF, Lesar M, et al: Hodgkin disease: clinical utility of CT in initial staging and treatment. Radiology 169:17, 1988.
5. Mansfield CM, Fabian C, Jones S, et al: Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III, IV Hodgkin's disease. Cancer 66:2295, 1990.
6. Munker R, Stengel A, Stabler A, et al: Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Cancer 76:1460, 1995.
7. King DJ, Dawson AA, McDonald AF: Gallium scanning in lymphoma. Clin Radiol 31:729, 1980.
8. Blackwell EA, Joshua DE, McLaughlin AF, et al: Early supradiaphragmatic Hodgkin's disease. High-dose gallium scanning obviates the need for staging laparotomy. Cancer 58:883, 1986.
9. Devizzi L, Maffiolo L, Bonfante V, et al: Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease. Ann Oncol 8:S53, 1997.
10. Gupta RK, Gospodarowicz MK, Lister TA: Clinical evaluation and staging of Hodgkin's disease. In: Mauch P, Armitage J, Diehl V, et al., eds. Hodgkin's Disease. Philadelphia: Lippincott, Williams & Wilkins, 1999, pp 223-40.
11. Salloum E, Brandt DS, Caride VJ, et al: Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol 15:518, 1997.
12. 18FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med 42:601, 2001.
13. Hoh CK, Glapsy J, Rosen P, et al: Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38:343, 1997.
14. Kaplan WD, Jochelson MS, Herman TS, et al: Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966, 1990.
15. Front D, Ben-Haim S, Israel O, et al: Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology 182:359, 1992.
16. 67Ga scintigraphy after one cycle of chemotherapy. Radiology 210:487, 1999.
17. Romer W, Hanauske AR, Ziegler S, et al: Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 91:4464, 1998.
18. Romer W, Schwaiger M: Positron emisson tomography in diagnosis and therapy monitoring of patients with lymphoma. Clinical Positron Imaging 1:101, 1998.
19. Newman JS, Francis IR, Kaminski MS, et al: Imaging lymphoma with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 190:111, 1994.
20. Stroobants S, Dupont P, Verhoef G, et al: Comparison of whole-body positron emission tomography and gallium-67 citrate imaging for staging of lymphoma [Abstract]. Blood 88:228a, 1996.
21. Carr R, Barrington SF, Madan B, et al: Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91: 3340, 1998.
22. Janicek M, Kaplan W, Neuberg D, et al: Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol 15:1631, 1997.
23. Moog F, Bangerter M, Diedrichs CG, et al: Extranodal malignant lymphoma: detection with FDG-PET versus CT. Radiology 206:475, 1998.
24. Gambhir SS, Czernin J, Schimmer J, et al: A tabulated review of the FDG-PET literature. J Nucl Med 42(Suppl):16S, 2001.
25. Lee JD, Park CH, Griffith J, et al: Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after treatment of Hodgkin's disease. J Nucl Med 33:1183, 1992.
26. Seabold JE, Votaw ML, Keyes JW Jr, et al: Gallium citrate Ga-67 scanning: clinical usefulness in lymphoma patients. Arch Intern Med 136:1370, 1976.
27. Lister TA, Crowther D, Sutcliffe SB, et al: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630, 1989.
28. Mendenhall NP, Cantor AB, Williams JL, et al: With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study. J Clin Oncol 11:2218, 1993.
29. Murrell HJ, Perry MC, Muscato JJ, et al: Hodgkin's disease: Is staging laparotomy still necessary? Semin Oncol 22:xv, 1995.